Ibrahim, Qu co-author UNC study, question FDA genetic-screening guidelines for cancer drug
August 28, 2007 Not everyone needs a genetic test before taking the cancer drug irinotecan, and the U.S. Food and Drug Administration should modify its prescription guidelines to say so, according to researchers at the University of North Carolina at Chapel Hill. Joseph Ibrahim, Ph.D., and Pingping Qu, Ph.D., of the UNC School of Public... Read more »